To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours
Clinical trial NCT01921140 · COMPLETED
Trial details
- NCT number
- NCT01921140
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-24
- Primary completion
- 2014-04-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.